Skip to Content
 
Center for International Blood and Marrow Transplant Research

New Immunobiology Working Committee Co-Scientific Director

Main Content

New Immunobiology Working Committee Co-Scientific Director

Rohtesh Mehta, MD, MPH, MS

CIBMTR is proud to introduce Rohtesh Mehta, MD, MPH, MS, as a new co-Scientific Director of the Immunobiology Working Committee.

Dr. Mehta is an Associate Professor in Stem Cell Transplantation & Cellular Therapy at the University of Texas MD Anderson Cancer Center. He received his MD in 2002, MPH in epidemiology in 2006, and MS in clinical research in 2011.  He completed his residency in internal medicine in 2009 as well as fellowships in palliative care and hematology-oncology at the University of Pittsburgh Medical Center and in stem cell transplantation at the University of Texas MD Anderson Cancer Center.

During his fellowships, Dr. Mehta focused on generating cord-blood derived autologous T-cells for AML treatment and investigated NK cell biology for stem cell transplantation. This research culminated in leading a prospective clinical trial evaluating adoptive NK cell therapy in multiple myeloma patients undergoing autologous transplantation.

Dr. Mehta established and continues to chair the Donor Integrated Selection Consortium (DISCo), a collaborative involving HCT centers across the US, dedicated to the development and implementation of evidence-based contemporary donor selection strategies and comprehensive transplant approaches. Through the years, he has initiated and collaborated on multiple CIBMTR studies investigating the role of donor-related HLA and non-HLA factors. His involvement in practice-changing research includes insights into the efficacy and safety of alternative donor HCT and factors for optimizing donor selection for best patient outcomes.

His publication record includes more than 145 peer-reviewed manuscripts, including corresponding and lead author studies in immunobiology and HCT and recent studies employing machine learning approaches. International organizations recognize Dr. Mehta as a leader in the field, as evidenced by invitations to speak and chair plenary sessions at transplantation, histocompatibility, and cellular therapy conferences worldwide. He is also dedicated to mentoring and training future leaders in HCT as shown by the multiple completed and ongoing studies with junior faculty and trainees.

CIBMTR selected Dr. Mehta through an extensive interview process, with special thanks to leaders and administrators at NMDP and the Medical College of Wisconsin.

Please join CIBMTR in welcoming him as a CIBMTR Scientific Director.